AlloVir, Inc.

Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of AlloVir, Inc. (NASDAQ: ALVR) between March 22, 2022 and December 21, 2023, both dates inclusive (the “Class Period”). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than March 19, 2024.

If you purchased AlloVir securities during the Class Period and would like to join the action, please click “Join This Class Action.”

集体诉讼期:March 22, 2022 through December 21, 2023
If you purchased AlloVir securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.


According to the lawsuit, defendants made false and/or misleading statements and/or failed to disclose that:

  • the global phase 3 studies of its lead product posoleucel for the prevention of life-threatening viral infections (the “posoleucel Phase 3 Studies”) were unlikely to meet their primary endpoints;
  • as a result, it was likely that AlloVir would ultimately discontinue the posoleucel phase 3 studies;
  • accordingly, AlloVir overstated the efficacy and clinical and/or commercial prospects of posoleucel; and
  • as a result, AlloVir’s public statements were materially false and misleading at all relevant times.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Attorney Advertising. Prior results do not guarantee a similar outcome.

公司名称: AlloVir, Inc.
股票代号: ALVR
集体诉讼期: March 22, 2022 through December 21, 2023
法院: United States District Court District of Massachusetts


自 2013 年以来,罗森律师事务所每年都是代表投资者成功提起证券集体诉讼的前四大律所之一。仅 2019 年,本律所就为投资者追回 4.38 亿美元资金。


机构股东服务公司按 2017 年证券集体诉讼索赔数量,罗森律师事务所列为第一名。